Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sun Pharmaceutical Industries Ltd eases for fifth straight session
Sun Pharmaceutical Industries Ltd is quoting at Rs 1689.8, down 0.22% on the day as on 13:19 IST on the NSE. The stock jumped 1.41% in last one year as compared to a 3.17% rally in NIFTY and a 8.74% spurt in the Nifty Pharma index.
Nifty Pharma index drops 3% as US tariff fears hit Sun Pharma, peers
A Bloomberg report indicated that the Trump administration is planning tariffs on pharmaceutical companies that have not entered into agreements to ensure lower drug prices in the US.
Sun Pharma’s Ilumya expansion bid gets USFDA nod for review
Sun Pharmaceutical has received a significant approval from the USFDA. The company's innovative drug, Ilumya, is now being considered for treating adults with active psoriatic arthritis. This marks a crucial step for Sun Pharma in expanding its medicine portfolio. The US regulator has accepted the application for review.
Nomura’s Saion Mukherjee picks Dr Reddy’s as top pharma bet amid semaglutide opportunity
Saion Mukherjee, Managing Director & Head of Equity Research at Nomura says Indian pharmaceutical companies are preparing to tap the opportunity as semaglutide goes off patent. While several large firms such as Sun Pharma, Lupin and Zydus could benefit from the growing diabetes and obesity drug market, Mukherjee highlighted Dr Reddy’s as his top pick in the sector. He said the opportunity will play out across domestic and global markets, with semaglutide likely to become an important growth driver for Indian pharma companies in the coming years.
Nifty Pharma index soars 7% thus far in February; nears 52-week high
Thus far in the month of February 2026, Laurus Labs surged 13%, while Sun Pharmaceutical Industries and Torrent Pharmaceuticals soared 11% each.
Trade Spotlight: How should you trade Bharat Electronics, Natco Pharma, Thermax, Sun Pharmaceutical, Kirloskar Oil Engines, and others on March 9?
Bears are likely to hold the fort, with the previous week's low at major risk amid geopolitical tensions in the Middle East. Below are some short-term trading ideas to consider.
Buy Sun Pharmaceutical Industries; target of Rs 2070: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 2070 in its research report dated May 25, 2026.
Buy Sun Pharmaceutical Industries; target of Rs 2000: ICICI Securities
ICICI Securities is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 2000 in its research report dated April 28, 2026.
Stocks to Watch Today: Tata Motors, Andhra Cements, Sun Pharma, GMDC, Axiscades, Power Mech, Zydus Lifesciences, Bajaj Electricals in focus on 17 March
Stocks to Watch, 17 March: Stocks like Reliance Industries, Tata Motors, Andhra Cements, Sun Pharmaceutical Industries, Rail Vikas Nigam, Gujarat Mineral Development Corporation, Axiscades Technologies, Power Mech Projects, Redington, and Zydus Lifesciences will be in focus on March 17.